Evaluation of Efficacy of Atenolol and Diltiazem-Sr in the Treatment of Hypertension

姚雪艳,范维琥,陈君柱,朱建华,陈宝仙,刘晓健
DOI: https://doi.org/10.3760/j:issn:0253-3758.2002.12.009
2002-01-01
Abstract:Objective To compare the efficacy of atenolol and diltiazem SR in the treatment of silent myocardial ischemia (SMI) and hypertension Methods Seventy three patients with mild to moderate hypertension and SMI were randomly allocated to be treated by atenolol 25 mg/d (group A, n =37) or diltiazem SR 90 mg/d (group D, n =36) for eight weeks The changes of heart rate, office blood pressure(OBP), ambulatory blood pressure(ABP) and SMI during 48 hour ambulatory electrocardiography were compared before and eight weeks after treatment Results OBP and ABP were lower under both regimes During 48 hour ambulatory electrocardiography, the frequency of ischemic episodes decreased by 59 9% with atenolol, 86 6% with diltiazem SR Total ischemic duration decreased by 44 9% with atenolol, 84 7% with diltiazem SR Side effects were 21 6% in group A and 11 1% in group D, respectively Conclusion Diltiazem SR is more effective and better tolerated in the treatment of the silent myocardial ischemia and hypertension
What problem does this paper attempt to address?